文献速递肝胆胰外科胃肠外科

门静脉栓塞后腹腔镜与开腹右肝切除治疗结直肠癌肝转移的国际多中心研究

Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
PubMed 文献 · Br J Surg · 2024-01-01

这项国际回顾性多中心研究比较了门静脉栓塞后腹腔镜与开腹右半肝切除治疗结直肠癌肝转移的围手术期和肿瘤学结局。倾向性评分匹配后每组78例,腹腔镜组手术时间和Pringle时间更长、住院时间更短,R0切除率、无病生存和总生存无显著差异。

要点

  • 门静脉栓塞后腹腔镜右肝切除较开腹手术优势有限。
  • 腹腔镜组手术时间和Pringle时间更长,但住院时间更短。
  • 匹配后两组R0切除率及生存结局无显著差异。

核心结论

  • 门静脉栓塞后腹腔镜(扩大)右肝切除治疗结直肠癌肝转移较开腹手术的优势有限。

研究设计与样本

  • 国际回顾性多中心研究纳入2004至2020年门静脉栓塞后行开腹或腹腔镜右半肝及扩大右半肝切除的结直肠癌肝转移患者338例,其中腹腔镜84例、开腹254例,采用倾向性评分匹配比较围手术期和肿瘤学结局。

主要发现

  • 腹腔镜组较少行扩大右半肝切除(18% vs 34.6%,P=0.004)、二步肝切除(42% vs 65%,P<0.001)和同期重大手术(4% vs 16.1%,P=0.003)。
  • 倾向性评分匹配后每组78例,腹腔镜组手术时间更长(330 vs 258.5 min,P<0.001)、Pringle时间更长(65 vs 30 min,P=0.001)、住院时间更短(7 vs 8天,P=0.011)。
  • R0切除率无差异(腹腔镜71% vs 开腹60%,P=0.230)。
  • 中位无病生存期腹腔镜12个月(95%CI 10-20)vs 开腹20个月(95%CI 13-31),P=0.145。
  • 中位总生存期腹腔镜28个月(95%CI 22-48)vs 开腹42个月(95%CI 35-52),P=0.614。

临床怎么用

  • 门静脉栓塞后需行右半肝切除的结直肠癌肝转移患者,腹腔镜手术可作为可选术式,但需权衡更长的手术和Pringle时间。

局限性

  • 回顾性多中心设计可能存在选择偏倚,腹腔镜组较少行扩大右半肝切除和二步肝切除。
  • 匹配后样本量较小(每组78例),生存分析可能把握度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver surgery is increasingly used for more challenging procedures. The aim of this study was to assess the feasibility and oncological safety of laparoscopic right hepatectomy for colorectal liver metastases after portal vein embolization. METHODS: This was an international retrospective multicentre study of patients with colorectal liver metastases who underwent open or laparoscopic right and extended right hepatectomy after portal vein embolization between 2004 and 2020. The perioperative and oncological outcomes for patients who underwent laparoscopic and open approaches were compared using propensity score matching. RESULTS: Of 338 patients, 84 patients underwent a laparoscopic procedure and 254 patients underwent an open procedure. Patients in the laparoscopic group less often underwent extended right hepatectomy (18% versus 34.6% (P = 0.004)), procedures in the setting of a two-stage hepatectomy (42% versus 65% (P < 0.001)), and major concurrent procedures (4% versus 16.1% (P = 0.003)). After propensity score matching, 78 patients remained in each group. The laparoscopic approach was associated with longer operating and Pringle times (330 versus 258.5 min (P < 0.001) and 65 versus 30 min (P = 0.001) respectively) and a shorter length of stay (7 versus 8 days (P = 0.011)). The R0 resection rate was not different (71% for the laparoscopic approach versus 60% for the open approach (P = 0.230)). The median disease-free survival was 12 (95% c.i. 10 to 20) months for the laparoscopic approach versus 20 (95% c.i. 13 to 31) months for the open approach (P = 0.145). The median overall survival was 28 (95% c.i. 22 to 48) months for the laparoscopic approach versus 42 (95% c.i. 35 to 52) months for the open approach (P = 0.614). CONCLUSION: The advantages of a laparoscopic over an open approach for (extended) right hepatectomy for colorectal liver metastases after portal vein embolization are limited.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Bozkurt E, Sijberden JP, Langella S, et al. Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study. Br J Surg. 2024. PMID: 39136268. doi:10.1093/bjs/znae181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。